Home › Autoimmune Diseases › Massachusetts › Worcester
Autoimmune Diseases clinical trials in Worcester, MA
4 studies for Autoimmune Diseases are looking for participants at sites in and around Worcester (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- University of Massachusetts Chan Medical School, Worcester
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecruitingPhase 1/2
- UMass Memorial Hospital, Worcester
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- University of Massachusetts Chan Medical School, Worcester
Testimonials and Navigation in Rheumatology
Recruiting
- University of Massachusetts Chan Medical School, Worcester
About Autoimmune Diseases
Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.
More about Autoimmune Diseases on MedlinePlus
Autoimmune Diseases trials in other cities
- Houston, TX21 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Philadelphia, PA16 studies
- Durham, NC15 studies
- Boston, MA13 studies
- Los Angeles, CA12 studies
- Chicago, IL12 studies
- Dallas, TX9 studies
- Portland, OR8 studies
- Atlanta, GA8 studies
- Milwaukee, WI8 studies
Other studies in Worcester
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Cancer (all types)7 studies
- Breast Cancer6 studies
- Schizophrenia5 studies
- Acute Myeloid Leukemia5 studies
- Metastatic Cancer5 studies
- Major Depressive Disorder5 studies
- Prostate Cancer5 studies
- Depression5 studies
- Ovarian Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.